Table 1.

Risk of Human Mpox Diagnosis, According to Subgroup.

Variable	Odds Ratio (95% CI)
	Unadjusted	Adjusted*
Vaccine type
ACAM2000	0.44 (0.26–0.70)	0.25 (0.15–0.42)
Dryvax	0.39 (0.19–0.75)	0.28 (0.13–0.58)
Age group
35–44 yr	0.96 (0.67–1.37)	0.84 (0.55–1.28)
45–64 yr	0.50 (0.36–0.70)	0.34 (0.23–0.49)
≥65 yr	0.05 (0.02–0.11)	0.04 (0.01–0.08)
Race or ethnic group†
Black	1.73 (1.26–2.40)	1.29 (0.90–1.87)
Hispanic	1.24 (0.83–1.85)	1.00 (0.64–1.55)
Other or unknown	1.34 (0.74–2.36)	0.90 (0.46–1.66)
Male sex	7.39 (3.28–21.18)	6.83 (2.95–19.89)
HIV diagnosis	2.89 (2.15–3.89)	2.34 (1.65–3.35)

^*The logistic regression model was adjusted for age, race, sex, and HIV status.

^†Race or ethnic group was reported by the participants. White race was used as the reference group in this analysis.